Inducible repair and the two forms of tumour hypoxia - Time for a paradigm shift

Acta Oncologica

Volumn 38, Issue 7, 1999, Pages 903-918

  Denekamp, Juliana ^a   Dau, Alexandru ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CELL HYPOXIA; CELL REGENERATION; CELL SURVIVAL; MATHEMATICAL MODEL; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; TISSUE OXYGENATION;

CELL HYPOXIA; CELL SURVIVAL; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; RADIATION TOLERANCE;

EID: 0032756201     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699432590     Document Type: Article

References (109)

1. Thames HD, Hendry JH. Fractionation in radiotherapy. London: Taylor & Francis, 1987.
2. Steel GG, ed. The radiobiology of human cells and tissues. Proc 15th L. H. Gray Conference. London: Taylor & Francis, 1989.
3. Pötten CS, Hendry JH, eds. Cell clones: manual of mammalian cell techniques. Edinburgh: Churchill Livingstone, 1985.
4. Courtenay VD, Selby PJ, Smith IE, Mills J, Peckham MJ. Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer 1978; 38: 77-81.
5. Arlett CF, Harcourt SA. Survey of radiosensitivity in a variety of human cell strains. Cancer Res 1980; 40: 926-32.
6. Fertil B, Malaise E-P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiât Oncol Biol Phys 1981; 7: 621-9.
7. Duchesne GM, Peacock JH, Steel GG. The acute in vitro and in vivo radiosensitivity of human lung tumour lines. Radiother Oncol 1986; 7: 353-61.
8. Malaise E-P, Fertil B, Deschavanne PJ, Chavaudra N, Brock WA. Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts. Radiât Res 1987; 111: 319-33.
9. Brock WA, Baker FL, Peters LJ. Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability. Int J Radiât Biol I989; 56: 751-60.
10. West CM, Scott D, Peacock JH. The Association for Radiation Research First Workshop: report. Normal cell radiosensitivity: clinical application in predicting response to radiotherapy and cancer predisposition 21-23 March, 1994, Westlakes Research Institute, Cumbria, UK. Int J Radiât Biol 1994; 66: 231-4.
11. West CM. Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol 1995; 68: 827-37.
12. Lambin P, Malaise EP, Joiner MC. Might intrinsic radioresistance of human tumour cells be induced by radiation? Int J Radiât Biol 1996; 69: 279-90.
13. Bjork-Eriksson T, West CM, Karlsson E, et al. The in vitro radiosensitivity of human head and neck cancers. Br J Cancer 1998; 77: 2371-5.
14. Begg AC, Hofland I, Moonen L, et al. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiât Oncol Biol Phys 1990; 19: 1449-53.
15. Wilson GD, Dische S, Saunders MI. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother Oncol 1995; 36: 189-97.
16. Fowler JF, Lindstrofn MJ. Loss of local control with prolongation in radiotherapy. Int J Radiât Oncol Biol Phys 1992; 23: 457-67.
17. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953; 26: 638-48.
18. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955; 9: 539-49.
19. Denekamp J, Joiner MC. The potential benefit from a perfect radiosensitizer and its dependence on reoxygenation. Br J Radiol 1982; 55: 657-63.
20. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 644-65.
21. Stone HB, Brown JM, Phillips TL, Sutherland RM. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiât Res 1993; 136: 422-34.
22. Vaupel P, Thews O, Kelleher DK, Hoeckel M. Current status of knowledge and critical issues in tumor oxygénation. Results from 25 years' research in tumor pathophysiology. Adv Exp Med Biol 1998; 454: 591-602.
23. Hodgkiss RJ, Begg AC, Middleton RW, et al. Fluorescent markers for hypoxic cells. A study of novel heterocyclic compounds that undergo bio-reductive binding. Biochem Pharmacol 1991; 41: 533-41.
24. Hodgkiss RJ, Webster L, Wilson. GD. Development of bioreductive markers for tumour hypoxia. Acta Oncol 1995; 34: 351-5.
25. Evans SM, Jenkins \VT, Joiner B, Lord EM, Koch CJ. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Res 1996; 56: 405-11.
26. Raleigh JA, Miller CG, Franko AJ, Koch CJ, Fuciarelli AF, Kelly DA. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br J Cancer 1987; 56: 395-400.
27. Brown JM. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 1979; 52: 650-6.
28. Chaplin DJ, Durand RE, Olive PL. Acute hypoxia in tumors: implications for modifiers of radiation effects. Int J Radiât Oncol Biol Phys 1986; 12: 1279-82.
29. Pigott KH, Hill SA, Chaplin DJ, Saunders MI. Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry. Radiother Oncol 1996; 40: 45-50.
30. Rofstad EK, DeMuth P, Fenton BM, Ceckler TL, Sutherland RM. 31P NMR spectroscopy and HbO2 cryospectrophotometry in prediction of tumor radioresistance caused by hypoxia. Int J Radiât Oncol Biol Phys 1989; 16: 919-23.
31. Okunieff P, McFarland E, Rummeny E, et al. Effects of oxygen on the metabolism of murine tumors using in vivo phosphorus-31 NMR. Am J Clin Oncol 1987; 10: 475-82.
32. Adams GE, Bremner JC, Stratford IJ, Wood PJ. Can 31P magnetic resonance spectroscopy measurements of changes in experimental tumour metabolism be related to modification of oxygénation status. Br J Radiol 1992; 23 (Suppl 24): 137-41.
33. Gerweck LE, Koutcher JA, Zaidi ST, Seneviratne T. Energy status in the murine FSall and MCalV tumors under aerobic and hypoxic conditions: an in vivo and in vitro analysis. Int J Radiât Oncol Biol Phys 1992; 23: 557-61.
34. Gerweck LE, Koutcher J, Zaidi ST. Energy status parameters, hypoxia fraction and radiocurability across tumor types. Acta Oncol 1995; 34: 335-8.
35. Chadwick KH, Leenhouts HP. A molecular theory of cell survival. Phys Med Biol 1973; 18: 78-87.
36. Douglas BG, Fowler JF. Fractionation schedules and a quadratic dose-effect relationship. Br J Radiol 1975; 48: 502-4.
37. Barendsen GW. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiât Oncol Biol Phys 1982; 8: 1981-97.
38. Joiner MC, Denekamp J, Maughan RL. The use of 'top-up' experiments to investigate the effect of very small doses per fraction in mouse skin. Int J Radiât Biol 1986; 49: 565-80.
39. Joiner MC, Johns H. Renal damage in the mouse: the response to very small doses per fraction. Radiât Res 1988; 114: 385-98.
40. Marples B, Joiner MC. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population. Radiât Res 1993; 133:41-51.
41. Lambin P, Marples B, Fertil B, Malaise EP, Joiner MC. Hypersensitivity of a human tumour cell line to very low radiation doses. Int J Radiât Biol 1993; 63: 639-50.
42. Marples B, Joiner MC, Skov KA. The effect of oxygen on low-dose hypersensitivity and increased radioresistance in Chinese hamster V79-379A cells. Radiât Res 1994; 138: S17-20.
43. Singh B, Arrand JE, Joiner MC. Hypersensitive response of normal human lung epithelial cells at low radiation doses. Int J Radiât Biol 1994; 65: 457-64.
44. Wouters BG, Skarsgard LD. The response of a human tumor cell line to low radiation doses: evidence of enhanced sensitivity. Radiât Res 1994; 138: S76-80.
45. Joiner MC, Lambin P, Malaise EP, et al. Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutât Res 1996; 358: 171-83.
46. Wouters BG, Sy AM, Skarsgard LD. Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity. Radiât Res 1996; 146: 399-413.
47. Wouters BG, Skarsgard LD. Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the 'adaptive response' and cannot be explained by a subpopulation of sensitive cells. Radial Res 1997; 148: 435-42.
48. Alsbeih G, Raaphorst GP. Radiosensitive human cells at the crossroads: high split-dose recovery and diminished inducible response. Radiation Research Society Meeting, Rhode Island, May 1997: 162. (abst).
49. Dasu A, Denekamp J. Inducible repair and intrinsic radiosensitivity: a complex but predictable relationship. Radiât Res 1999 (in press).
50. Dasu A, Denekamp J. New insights into factors influencing the .clinically relevant oxygen enhancement ratio. Radiother Oncol 1998; 46: 269-77.
51. Denekamp J, Dasu A, Waites A. Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy? Adv Enzyme Regul 1998; 38: 281-99.
52. Denekamp J, Da$u A, Waites A, Littbrand B. Hyperfractionation as an effective way of overcoming radioresistance. Int J Radiât Oncol Biol Phys 1998; 42: 705-9.
53. Dacu A, Denekamp J. Superfractionation as a potential hypoxic cell radiosensitiser: prediction of an optimum dose per fraction. Int J Radial Oncol Biol Phys 1999; 43: 108394.
54. Hall EJ, Bedford JS, Oliver R. Extreme hypoxia; its effect on the survival of mammalian cells irradiated at high and low dose-rates. Br J Radiol 1966; 39: 302-7.
55. Howard A. The oxygen requirement for recovery in splitdose experiments with Oedogonium. Int J Radiât Biol 1968; 14: 341-50.
56. Berry RJ, Hall EJ, Cavanagh J. Survival of mammalian cells in confluent culture ('stationary phase') irradiated under aerobic and hypoxic conditions: its implications for radiotherapy. Br J Radiol 1969; 42: 719.
57. Hall EJ, Cavanagh J. The effect of hypoxia on recovery of sublethal radiation damage in Vicia seedlings. Br J Radiol 1969; 42: 270-7.
58. Hall EJ. The effect of hypoxia on the repair of sublethal radiation damage in cultured mammalian cells. Radiât Res 1972; 49: 405-15.
59. Nagle WA, Moss Jr. AJ, Roberts Jr. HG, Baker-Max L. Effects of 5-thio-D-glucose on cellular adenosine triphosphate levels and deoxyribonucleic acid rejoining in hypoxic and aerobic Chinese hamster cells. Radiology 1980; 137: 203-11.
60. Spiro IJ, Kennedy KA, Stickler R, Ling CC. Cellular and molecular repair of x-ray-induced damage: dependence on oxygen tension and nutritional status. Radiât Res 1985; 101: 144-55.
61. Ling CC, Robinson E, Shrieve DC. Repair of radiation induced damage-dependence on oxygen and energy status. Int J Radiât Oncol Biol Phys 1988; 15: 1179-86.
62. Trott KR. Tumour stem cells: the biological concept and its application in cancer treatment. Radiother Oncol 1994; 30: 1-5.
63. Denekamp J. Tumour slem cells: facts, interpretation and consequences. Radiother Oncol 1994; 30: 6-10.
64. Koval TM. Multiphasic survival response of a radioresistant lepidopteran insect cell line. Radiât Res 1984; 98: 642-8.
65. Marples B, Joiner MC, Skov KA. An x-ray inducible repair response: evidence from high resolution survival measurements in air and hypoxia. In: Sugahara T, Sagan LA, Aoyama T, eds. Low dose irradialion and biological defense mechanisms. Amsterdam: Elsevier, 1992: 295-8.
66. Durand RE, Sutherland RM. Effects of intercellular contact on repair of radiation damage. Exp Cell Res 1972; 71: 75-80.
67. Sutherland RM, Durand RE. Cell contact as a possible contribution to radiation resistance of some tumours. Br J Radiol 1972; 45: 788-9.
68. Durand RE, Sutherland RM. Radiation-resistant tumor cells may be more sensitive in vitro. Cancer Res 1972; 32: 2587-8.
69. Alper T. Cellular radiobiology. Cambridge: Cambridge University Press, 1979.
70. Beck-Bornholdt H-P, Maurer T, Decker S, Omniczynski M, Vogler H, Würschmidt F. Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation-126 fractions applied within 6 weeks. Int J Radiât Oncol Biol Phys 1989; 16: 701-5.
71. Hamilton CS, Denham JW, O'Brien M, et al. Underprediction of human skin erythema at low doses per fraction by the linear quadratic model. Radiother Oncol 1996; 40: 23-30.
72. Reinhold HS. The influence of radiation on blood vessels and circulation. Chapter IV. Structural changes in blood vessels. Curr Top Radiât Res Q 1974; 10: 58-74.
73. Reinhold HS, Blachiwiecz B, Blök A. Oxygénation and reoxygenation in 'sandwich' tumours. Bibl Anat 1977; 270272.
74. Ward-Hartley KA, Jain RK. Effect of glucose and galactose on microcirculatory flow in normal and neoplastic tissues in rabbits. Cancer Res 1987; 47: 371-7.
75. Foltz RM, McLendon RE, Friedman HS, Dodge RK, Bigner DD, Dewhirst M\V. A pial window model for the intracranial study of human glioma microvascular function. Neurosurgery 1995; 36: 976-84.
76. Kimura H, Braun RD, Ong ET, et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 1996; 56: 5522-8.
77. Alper T, Howard-Flanders P. The role of oxygen in modifying the radiosensitivity of E. coli B. Nature, Lond 1956; 178: 978-9.
78. Deschner E, Gray LH. Influence of oxygen tension on x-ray-induced chromosomal damage in Erlich ascites tumor cells irradiated in vitro and in vivo. Radiât Res 1959; 11: 115-46.
79. Koch CJ, Kruuv J, Frey HE. Variation in radiation response of mammalian cells as a function of oxygen tension. Radiât Res 1973; 53: 33-42.
80. Michael BD, Adams GE, Hewitt HB, Jones WB, Watts ME. A posteffect of oxygen in irradiated bacteria: a submillisecond fast mixing study. Radial Res 1973; 54: 239-51.
81. Koch CJ, Meneses JJ, Harris JW. The effect of extreme hypoxia and glucose on the repair of potentially lethal and sublethal radiation damage by mammalian cells. Radiât Res 1977; 70: 542-51.
82. Watts ME, Maughan RL, Michael BD. Fast kinetics of the oxygen effect in irradiated mammalian cells. Int J Radiât Biol 1978; 33: 195-9.
83. Franko AJ, Sutherland RM. Rate of death of hypoxic cells in multicell spheroids. Radiât Res 1978; 76: 561-72.
84. Franko AJ, Sutherland RM. Radiation survival of cells from spheroids grown in different oxygen concentrations. Radiât Res 1979; 79: 454-67.
85. Kwok TT, Sutherland RM. Reoxygenation associated radiosensitization after chronic hypoxia: effect of temperature and oxygen tension. Int J Radiât Oncol Biol Phys 1992; 22: 411-4.
86. Gerwcck LE, Seneviratne T, Gerweck KK. Energy status and radiobiological hypoxia at specified oxygen concentrations. Radiât Res 1993; 135: 69-74.
87. Hirst DG, Denekamp J. Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet 1979; 12: 31-42.
88. Hirst DG, Denekamp J, Hobson B. Proliferation kinetics of endothelial and tumour cells in three mouse mammary carcinomas. Cell Tissue Kinet 1982; 15: 251-61.
89. Denekamp J, Michael BD, Harris SR. Hypoxie cell radiosensitisers: Comparative tests of some electron affinic compounds using epidermal cell survival in vivo. Radiât Res 1974; 60: 119-32.
90. Mueller-Klieser W, Schaefer C, Walenta S, Rofstad EK, Fenton BM, Sutherland RM. Assessment of tumor energy and oxygénation status by bioluminescence, nuclear magnetic resonance spectroscopy, and cryospectrophotometry. Cancer Res 1990; 50: 1681-5.
91. Nordsmark M, Keller J, Nielsen OS, Lundorf E, Overgaard J. Tumour oxygénation assessed by polarographic needle electrodes and bioenergetic status measured by 31P magnetic resonance spectroscopy in human soft tissue tumours. Acta Oncol 1997; 36: 565-71.
92. Robinson SP, Howe FA, Rodrigues LM, Stubbs M, Griffiths JR. Magnetic resonance imaging techniques for monitoring changes in tumor oxygénation and blood flow. Semin Radiât Oncol 1998; 8: 197-207.
93. Hossmann KA, Linn F, Okada Y. Bioluminescence and fluoroscopic imaging of tissue pH and metabolites in experimental brain tumors of cat. NMR Biomed 1992; 5: 259-64.
94. Oberhaensli RD, Hilton-Jones D, Bore PJ, Hands LJ, Rampling RP, Radda GK. Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet 1986; 2: 8-11.
95. Rasey JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [I8F]fiuoromisonidazole: a pretherapy study of 37 patients. Int J Radiât Oncol Biol Phys 1996; 36: 417-28.
96. Kallinowski F, Zander R, Hoeckel M, Vaupel P. Tumor tissue oxygénation as evaluated by computerized-pO2-histography. Int J Radiât Oncol Biol Phys 1990; 19: 953-61.
97. Arteel GE, Thurman RG, Raleigh JA. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem 1997; 253: 743-50.
98. Varia MA, Calkins-Adams DP, Rinker LH, et al. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol 1998; 71: 270-7.
99. Waites A, Denekamp J. Computer simulation of microelectrode measurements of regional oxygen tensions in a corded tumour model. 1999 (in preparation).
100. Höckel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56: 4509-15.
101. Kolstad P. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand J Clin Lab Invest 1968; 106 (Suppl): 145-57.
102. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygénation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996; 41: 31-9.
103. Siemann DW, Hill RP, Bush RS. The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcoma. Int J Radiât Oncol Biol Phys 1977; 2: 903-11.
104. Kaanders JH, Pop LA, Marres HA, et al. Accelerated radiotherapy with carbogen and nicotinamide (ARGON) for laryngeal cancer. Radiother Oncol 1998; 48: 115-22.
105. Suit HD, Brown JM. Relative efficacy of high-pressure oxygen and misonidazole to reduce TCD50 of a mouse mammary carcinoma. Br J Radiol 1979; 52: 159-60.
106. Balmukhanov SB, Aitkulova ZK, Mustafin ZS, Rismukhamedova RS, Filippenko VI. Intratumoral and parametric administration of metronidazole in the radiotherapy of cancer of the cervix. Med Radiol Mosk 1989; 34: 26-30.
107. Pereslegin IA, Mufazalov FF. The frequency of recurrences and métastases of bladder cancer following a radical course of radiotherapy. Vestn Rentgenol Radiol 1992; 57-8.
108. Andreev VG, Mardynskii IS, Molotkova NG, et al. Combined therapy of malignant tumors of the upper jaw and nasal cavity using pre- and post-operative radiation with metronidazole radiomodification. Vopr Onkol 1996; 42: 813.
109. Overgaard J, Hansen HS, Overgaard M, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 1998; 46: 135-46.